The FOXP3 Protocol™ Autoimmune Wellness Program
FOR HEALTH PROFESSIONALS — NOBEL PRIZE–BASED SCIENCE
A Licensable, Nobel Prize–Based Program
A licensable, five-phase autoimmune wellness protocol grounded in the biology behind the 2025 Nobel Prize in Physiology or Medicine — the discovery of FOXP3 and regulatory T cells (Tregs).
A NEW CLINICAL FRAMEWORK
Add an Autoimmune-Focused Program to Your Practice
Regulatory T cells (Tregs) are the immune system’s built-in checkpoint against self-attack. The 2025 Nobel Prize in Physiology or Medicine recognized the researchers who identified FOXP3 as the master regulatory gene controlling Treg development — a discovery reshaping how the wellness and functional medicine fields think about immune balance.
The FOXP3 Protocol is a structured, five-phase program built on that science, developed by Ray Wisniewski, DC, and available to licensed practitioners who want a research-informed, standardized framework to offer autoimmune-focused clients — positioned as additive support alongside conventional medical care.
THE FIVE PHASES
WHY PRACTITIONERS ARE LOOKING AT THIS
What the FOXP3 Protocol Offers Your Practice
Standardized Framework
A structured, five-phase protocol you can apply consistently across autoimmune-focused clients.
Research-Informed
Grounded in Nobel Prize–recognized Treg/FOXP3 biology and current immunology literature.
Licensable Model
Available for licensing, with supporting materials and a compliance-reviewed patient education framework.
Complements W-T.ai Tools
Pairs with FoodPharmacy and other W-T.ai platform tools already in your practice.
About Dr. Ray: Ray Wisniewski, DC, is a licensed chiropractor and the developer of the FOXP3 Protocol, a wellness program grounded in the biology recognized by the 2025 Nobel Prize in Physiology or Medicine. He is the author of The FOXP3 Protocol for Women, a #1 Amazon bestseller, with a second title planned for release alongside the Nobel anniversary.
The FOXP3 Protocol is a wellness and nutritional support program. It is intended to be additive to, not a replacement for, conventional medical care provided by a licensed physician. Nothing on this page or at foxp3protocol.com should be interpreted as treating, curing, or reversing any disease.
The Nobel Prize Committee, the Nobel Foundation, and the 2025 laureates have not endorsed, reviewed, or participated in the development of the FOXP3 Protocol. References to the Nobel Prize describe the underlying scientific discovery only.
See the Full Protocol at FOXP3Protocol.com
Visit the practitioner resources on the full FOXP3 Protocol site to learn about licensing, certification, and program materials.